Complement. Second of two parts.

[1]  M. Pepys.  Cambridge University Natural Science Club, 1872 to 1972 , 1972, Nature.

[2]  M. Pepys.  ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO , 1974, The Journal of experimental medicine.

[3]  A. J. Mcadams,et al.  Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema. , 1977, Annals of internal medicine.

[4]  M. Pepys,et al.  Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. , 1988, The Journal of investigative dermatology.

[5]  M. Pepys,et al.  Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus , 1989, The Journal of experimental medicine.

[6]  T. Mack,et al.  A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[7]  W. Dreyer,et al.  Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. , 1994, Circulation research.

[8]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[9]  D. Fearon,et al.  Activation of B lymphocytes: integrating signals from CD19, CD22 and FcγRIIb1 , 1996 .

[10]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[11]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[12]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[13]  M. Kazatchkine,et al.  Autoantibodies against C1q: view on clinical relevance and pathogenic roles , 1999, Clinical and experimental immunology.

[14]  P. Butler,et al.  Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.

[15]  L. Herzenberg,et al.  Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[17]  P. Taylor,et al.  Systemic lupus erythematosus, complement deficiency, and apoptosis. , 2000, Advances in immunology.

[18]  S. Meri,et al.  Complement activation after oxidative stress: role of the lectin complement pathway. , 2000, The American journal of pathology.

[19]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[20]  T. Fujita,et al.  Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1 , 2000, The Journal of Immunology.

[21]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[22]  Jianzhu Chen,et al.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Carroll,et al.  The role of complement in B cell activation and tolerance. , 2000, Advances in immunology.

[24]  A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. , 2000 .

[25]  M. Neuberger,et al.  Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies , 2000, The Journal of experimental medicine.

[26]  B. Heyman,et al.  Regulation of antibody responses via antibodies, complement, and Fc receptors. , 2000, Annual review of immunology.